NLRP3 and lung cancer: To examine whether NLRP3 inflammasome activation is involved in increased lung tumor development in Nr1d1−/− mice, we treated mice with MCC950, a specific inhibitor of the NLRP3 inflammasome, in orthotopic LLC1 lung cancer models.